Cover Image

Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis

Abstract Background Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease worldwide. Current studies have shown that PNPLA3 (Patatin-like phospholipase domain containing 3) rs738409 G/C gene polymorphism is associated with adult nonalcoholic fatty liver d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shan Tang (Author), Jing Zhang (Author), Ting Ting Mei (Author), Hai Qing Guo (Author), Xin Huan Wei (Author), Wen Yan Zhang (Author), Ya Li Liu (Author), Shan Liang (Author), Zuo Peng Fan (Author), Li Xia Ma (Author), Wei Lin (Author), Yi Rong Liu (Author), Li Xia Qiu (Author), Hai Bin Yu (Author)
Format:	Book
Published:	BMC, 2020-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of the rs738409 polymorphism in <it>PNPLA3 </it>with liver damage and the development of nonalcoholic fatty liver disease
by: Chayama Kazuaki, et al.
Published: (2010)

Association of PNPLA3 Gene Polymorphism (rs738409) and Nonalcoholic Fatty Liver Disease in Southern Iranian Population
by: Neda Choobini, et al.
Published: (2016)

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020)

An association study of the PNPLA3 I148M polymorphism (rs738409) with serum lipids in patients with dyslipidemia
by: Despoina Ioannidou, et al.
Published: (2023)

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
by: Daniel Lindén, et al.
Published: (2019)

Contribution of PNPLA3 gene polymorphisms to hepatocellular carcinoma susceptibility in the Chinese Han population
by: Dongwei Gong, et al.
Published: (2022)

Comment on "Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease"
by: Xia Li, et al.
Published: (2018)

Wendan decoction in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis
by: Yufeng Zhang, et al.
Published: (2022)

Ilexsaponin A1 Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism in Mice
by: Wen-wen Zhao, et al.
Published: (2021)

Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats
by: Long Li, et al.
Published: (2015)

PNPLA3 gene and kidney disease
by: Alessandro Mantovani, et al.
Published: (2020)

Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China
by: Lingxi Kong, et al.
Published: (2023)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021)

IL-4 polymorphisms (rs2227284, rs2243267, and rs2243270) are associated with reduced risk of rheumatoid arthritis
by: Xiaoli Liu, et al.
Published: (2024)

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
by: Tingting Yan, et al.
Published: (2020)

Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
by: Xianmin Dai, et al.
Published: (2021)

The relationship between folic acid and nonalcoholic fatty liver disease
by: Bing'er Xu, et al.
Published: (2024)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023)

Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus
by: Yanbo Fan, et al.
Published: (2018)

Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
by: Huixia Liu, et al.
Published: (2022)

<i>Ramulus Mori</i> (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
by: Yan-Min Chen, et al.
Published: (2022)

Astragaloside IV Improves High-Fat Diet-Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway
by: Ying-Li Liu, et al.
Published: (2021)

Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease
by: Guangyu Jiang, et al.
Published: (2020)

Corilagin Alleviates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced C57BL/6 Mice by Ameliorating Oxidative Stress and Restoring Autophagic Flux
by: Rong Zhang, et al.
Published: (2020)

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice
by: Qin-Juan Sun, et al.
Published: (2021)

Nonalcoholic Fatty Liver Disease An Update
Published: (2019)

Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity
by: Luting Peng, et al.
Published: (2021)

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
by: ChenLu Zhao, et al.
Published: (2023)

Polytropic Influence of TRIB3 rs2295490 Genetic Polymorphism on Response to Antihypertensive Agents in Patients With Essential Hypertension
by: Jiecan Zhou, et al.
Published: (2019)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
by: Hu Li, et al.
Published: (2022)

Endoplasmic reticulum stress response in nonalcoholic fatty liver disease
by: Arushana Ali, et al.
Published: (2018)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019)

Nonalcoholic Fatty Liver Disease and Ayurveda
by: Sanjeev Sharma, et al.
Published: (2023)

Novel PNPLA2 gene mutation in a child causing neutral lipid storage disease with myopathy
by: Shouyan Zheng, et al.
Published: (2018)

Untargeted Metabolomic Analysis of the Effects and Mechanism of Nuciferine Treatment on Rats With Nonalcoholic Fatty Liver Disease
by: Huantian Cui, et al.
Published: (2020)

Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
by: Xiao-Fang Yang, et al.
Published: (2021)

Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver
by: Feng Y, et al.
Published: (2022)

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
by: Yuting Ma, et al.
Published: (2021)

Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
by: Yuzhen Zhao, et al.
Published: (2019)